Lista de obras - Susan Stine - Dominio Público Uruguay

Bringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field experience

artículo científico publicado en 2004

Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review

artículo científico publicado en 2012

Characteristics of opioid-using pregnant women who accept or refuse participation in a clinical trial: screening results from the MOTHER study

artículo científico publicado en 2009

Cigarette Smoking and Neonatal Outcomes in Depressed and Non-Depressed Opioid-Dependent Agonist-Maintained Pregnant Patients

artículo científico publicado en 2011

Clinical characteristics of central European and North American samples of pregnant women screened for opioid agonist treatment.

artículo científico publicado en 2010

Co-occurring psychiatric symptoms are associated with increased psychological, social, and medical impairment in opioid dependent pregnant women

artículo científico publicado en 2010

Cocaine abuse and attention-deficit hyperactivity disorder: Implications of adult symptomatology

Comments on: Efficacy versus Effectiveness of Buprenorphine and Methadone Maintenance in Pregnancy

scientific article published on 01 January 2012

Desipramine and contingency management for cocaine and opiate dependence in buprenorphine maintained patients

artículo científico publicado en 2003

Differences in the profile of neonatal abstinence syndrome signs in methadone- versus buprenorphine-exposed neonates

artículo científico publicado en 2012

Effect of alpha-methyl-para-tyrosine on response to cocaine challenge

artículo científico publicado en 1997

Effect of hepatitis C virus status on liver enzymes in opioid-dependent pregnant women maintained on opioid-agonist medication

artículo científico publicado en 2012

Efficacy of dose and contingency management procedures in LAAM-maintained cocaine-dependent patients

artículo científico publicado en 2005

Fetal assessment before and after dosing with buprenorphine or methadone

artículo científico publicado en 2012

Induction of pregnant women onto opioid-agonist maintenance medication: an analysis of withdrawal symptoms and study retention

artículo científico publicado en 2013

Infections and obstetric outcomes in opioid-dependent pregnant women maintained on methadone or buprenorphine

artículo científico publicado en 2012

Inhibition of in situ metabolism of [3H](met5)-enkephalin and potentiation of (met5)-enkephalin analgesia by captopril

artículo científico publicado en 1980

Intrauterine abstinence syndrome (IAS) during buprenorphine inductions and methadone tapers: can we assure the safety of the fetus?

artículo científico publicado en 2012

Maternal Opioid Treatment: Human Experimental Research (MOTHER)--approach, issues and lessons learned

artículo científico publicado en 2012

Mazindol treatment for cocaine dependence

artículo científico publicado en 1995

Methadone patients exhibit increased startle and cortisol response after intravenous yohimbine

artículo científico publicado en 2001

Motivation Enhancement Therapy with pregnant substance-abusing women: does baseline motivation moderate efficacy?

artículo científico publicado en 2008

Neonatal Abstinence Syndrome After Methadone or Buprenorphine Exposure

Neonatal abstinence syndrome after methadone or buprenorphine exposure

artículo científico publicado en 2010

Nonserious adverse events in randomized trials with opioid-dependent pregnant women: direct versus indirect measurement

artículo científico publicado en 2012

Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone.

artículo científico publicado en 2003

Opioid dependence during pregnancy: relationships of anxiety and depression symptoms to treatment outcomes

artículo científico publicado en 2012

Predicting treatment for neonatal abstinence syndrome in infants born to women maintained on opioid agonist medication

artículo científico publicado en 2012

Predictors of outcome for short-term medically supervised opioid withdrawal during a randomized, multicenter trial of buprenorphine-naloxone and clonidine in the NIDA clinical trials network drug and alcohol dependence

artículo científico publicado en 2008

Psychopharmacologic management of opioid-dependent women during pregnancy

scientific article published on March 2009

Reduction of opiate withdrawal-like symptoms by cocaine abuse during methadone and buprenorphine maintenance

artículo científico publicado en 1994

Release of enkephalin-like immunoreactive material from isolated bovine chromaff in cells

artículo científico publicado en 1980

Treatment of opioid-dependent pregnant women: clinical and research issues

scientific article published on 14 January 2008

Unintended pregnancy in opioid-abusing women

artículo científico publicado en 2010

Yohimbine-induced withdrawal and anxiety symptoms in opioid-dependent patients

artículo científico publicado en 2002

Lista de obras de Susan Stine

Bringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field experience

Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review

Characteristics of opioid-using pregnant women who accept or refuse participation in a clinical trial: screening results from the MOTHER study

Cigarette Smoking and Neonatal Outcomes in Depressed and Non-Depressed Opioid-Dependent Agonist-Maintained Pregnant Patients

Clinical characteristics of central European and North American samples of pregnant women screened for opioid agonist treatment.

Co-occurring psychiatric symptoms are associated with increased psychological, social, and medical impairment in opioid dependent pregnant women

Cocaine abuse and attention-deficit hyperactivity disorder: Implications of adult symptomatology

Comments on: Efficacy versus Effectiveness of Buprenorphine and Methadone Maintenance in Pregnancy

Desipramine and contingency management for cocaine and opiate dependence in buprenorphine maintained patients

Differences in the profile of neonatal abstinence syndrome signs in methadone- versus buprenorphine-exposed neonates

Effect of alpha-methyl-para-tyrosine on response to cocaine challenge

Effect of hepatitis C virus status on liver enzymes in opioid-dependent pregnant women maintained on opioid-agonist medication

Efficacy of dose and contingency management procedures in LAAM-maintained cocaine-dependent patients

Fetal assessment before and after dosing with buprenorphine or methadone

Induction of pregnant women onto opioid-agonist maintenance medication: an analysis of withdrawal symptoms and study retention

Infections and obstetric outcomes in opioid-dependent pregnant women maintained on methadone or buprenorphine

Inhibition of in situ metabolism of [3H](met5)-enkephalin and potentiation of (met5)-enkephalin analgesia by captopril

Intrauterine abstinence syndrome (IAS) during buprenorphine inductions and methadone tapers: can we assure the safety of the fetus?

Maternal Opioid Treatment: Human Experimental Research (MOTHER)--approach, issues and lessons learned

Mazindol treatment for cocaine dependence

Methadone patients exhibit increased startle and cortisol response after intravenous yohimbine

Motivation Enhancement Therapy with pregnant substance-abusing women: does baseline motivation moderate efficacy?

Neonatal Abstinence Syndrome After Methadone or Buprenorphine Exposure

Neonatal abstinence syndrome after methadone or buprenorphine exposure

Nonserious adverse events in randomized trials with opioid-dependent pregnant women: direct versus indirect measurement

Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone.

Opioid dependence during pregnancy: relationships of anxiety and depression symptoms to treatment outcomes

Predicting treatment for neonatal abstinence syndrome in infants born to women maintained on opioid agonist medication

Predictors of outcome for short-term medically supervised opioid withdrawal during a randomized, multicenter trial of buprenorphine-naloxone and clonidine in the NIDA clinical trials network drug and alcohol dependence

Psychopharmacologic management of opioid-dependent women during pregnancy

Reduction of opiate withdrawal-like symptoms by cocaine abuse during methadone and buprenorphine maintenance

Release of enkephalin-like immunoreactive material from isolated bovine chromaff in cells

Treatment of opioid-dependent pregnant women: clinical and research issues

Unintended pregnancy in opioid-abusing women

Yohimbine-induced withdrawal and anxiety symptoms in opioid-dependent patients